Table 1.
Groups | ID | Neuromuscular symptom | Terminal point (dpi) | Euthanized (dpi) | Lethality (%) | ||
---|---|---|---|---|---|---|---|
Appearance (dpi) | Peak (dpi) | Recovery (dpi) | |||||
Non-treatment | 1 | 6 | 9 | – | 12 | – | 100 |
2 | 8 | 10 | – | 12 | – | ||
3 | 7 | 9 | – | 10 | – | ||
SC | 1 | 6 | 9 | – | 10 | – | 66.7 |
2 | 5 | 8 | – | 8 | – | ||
3 | 4 | 9 | 16 | – | 32 | ||
SC/SC | 1 | 6 | 8 | – | 10 | – | 100 |
2 | 6 | 10 | – | 10 | – | ||
3 | 6 | 9 | – | 9 | – | ||
SC/IT | 1 | 4 | 7 | 11 | – | 25 | 0 |
2 | 6 | 8 | 18 | – | 34 | ||
3 | 5 | 7 | 12 | – | 33 | ||
4 | 4 | 9 | 16 | – | 32 |
dpi, days post inoculation; SC, subcutaneous; IT, intrathecal.